The histone deacetylase 1 market is expanding as pharmaceutical companies and research institutions increase investment in epigenetic science, cancer research, neurodegenerative disease studies, and precision medicine. The market was valued at USD 1.04 billion in 2024 and is projected to reach USD 2.5 billion by 2035, growing at a CAGR of 8.3%. 1216
The Histone Deacetylase 1 Market includes...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek